Company intelligence / Profile preview

Biopharma

Bila Tserkva, Kyiv Oblast, Ukraine

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Biopharma is a leading Ukrainian pharmaceutical company specializing in the development and production of plasma-derived drugs, recombinant proteins, and probiotics. The company operates a state-of-the-art fractionation plant and plasma collection centers, positioning itself as a key player in the Eastern European blood products market. Its portfolio includes critical treatments such as immunoglobulins, coagulation factors, and albumin used in intensive care and immunology. Biopharma focuses on high-tech manufacturing and exports its products to over 30 countries globally.

Therapeutic areas: HematologyImmunologyInfectious DiseasesMetabolic Disorders
Modalities: BiologicProteinSmall moleculeVaccineProbiotic
Industry: Biotech

Partnerships

Stada ArzneimittelTakeda

Beyond the preview

Go deeper on Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biopharma.

Explore the full profile